Intellia Therapeutics, Inc.
Company Information
Industry In Vitro & In Vivo Diagnostic Substances
SIC Code 2835
Entity Type operating
SEC Category Large accelerated filer
State of Incorporation DE
Business Address 40 ERIE STREET, CAMBRIDGE, MA, 02139
Mailing Address 40 ERIE STREET, CAMBRIDGE, MA, 02139
Phone 857-285-6200
Fiscal Year End 1231
EIN 364785571
Financial Overview
FY2024
$523.51M
Cash & Equivalents
Recent SEC Filings
| Form Type | Date Filed | Document |
|---|---|---|
| SCHEDULE 13G/A Passive ownership amendment | February 12, 2026 | View on SEC |
| SCHEDULE 13G/A Passive ownership amendment | February 11, 2026 | View on SEC |
| SCHEDULE 13G Passive beneficial ownership (>5%) | February 9, 2026 | View on SEC |
| SCHEDULE 13G/A Passive ownership amendment | February 3, 2026 | View on SEC |
| SCHEDULE 13G/A Passive ownership amendment | January 30, 2026 | View on SEC |
| 8-K Current report of material events | January 27, 2026 | View on SEC |
| 8-K Current report of material events | January 9, 2026 | View on SEC |
| 4 Insider stock transaction report | January 7, 2026 | View on SEC |
| 4 Insider stock transaction report | January 7, 2026 | View on SEC |
| 4 Insider stock transaction report | January 7, 2026 | View on SEC |
Insider Trading
SELL 8 insiders
11 recent transactions
View Full Insider Trading Profile
Related Companies
Companies in the same industry (SIC: 2835)
QuidelOrtho Corp
QDEL In Vitro & In Vivo Diagnostic Substances
IDEXX LABORATORIES INC /DE
IDXX In Vitro & In Vivo Diagnostic Substances
Insight Molecular Diagnostics Inc.
IMDX In Vitro & In Vivo Diagnostic Substances
VOLITIONRX LTD
VNRX In Vitro & In Vivo Diagnostic Substances
NEOGEN CORP
NEOG In Vitro & In Vivo Diagnostic Substances
Investor Resources
Learn more about SEC filings and how to research public companies.
What is the SEC?
A plain English guide to the Securities and Exchange Commission
Understanding SEC Filings & CIK
How to navigate SEC filings and Central Index Keys
10-K Annual Reports Explained
Everything you need to know about annual reports
S-1 & F-1 IPO Filings
Understanding IPO registration statements
SEC EDGAR Database Guide
How to use the SEC's free filing database
Important Disclaimer
This AI-generated analysis is for informational purposes only and does not constitute financial or investment advice. Always consult with qualified professionals and conduct your own research before making investment decisions.